Sales of Roche's Tamiflu fall in late 2010
Sales of the antiviral drug Tamiflu, a money spinner for pharmaceutical group Roche during the 2009 flu pandemic, continued to fall in late 2010, in line with forecasts, the said indicated on Friday.
Media reports said sales of the drug should reach about 50 million Swiss francs (39.9 million euros, 52 million dollars) in the last quarter.
A spokeswoman for Roche said "the 50 million (levels) mentioned are in line with group forecasts."
Roche predicted in October that annual sales of Tamiflu should reach a "maximum" of one billion Swiss francs in 2010, compared to 3.2 billion in 2009.
Over the first nine months of last year sales, totalled 808 million francs, after dropping tenfold in the third quarter alone to 98 million francs.
The drug is regarded as a frontline treatment for severe influenza. Sales soared amid a rush by governments to stockpile the drug after the World Health Organisation declared a global pandemic over H1N1 swine flu in June 2009.
© 2011 AFP